Six types of human 17 -hydroxysteroid dehydrogenases catalyzing the conversion of estrogens and androgens at position C17 have been identified so far. The peroxisomal 17 -hydroxysteroid dehydrogenase type 4 (17 -HSD 4, gene name HSD17B4) catalyzes the oxidation of estradiol with high preference over the reduction of estrone. The highest levels of 17 -HSD 4 mRNA transcription and specific activity are found in liver and kidney followed by ovary and testes. A 3 kb mRNA codes for an 80 kDa (737 amino acids) protein featuring domains which are not present in the other 17 -HSDs. The N-terminal domain of 17 -HSD 4 reveals only 25% amino acid similarity with the other types of 17 -HSDs. The 80 kDa protein is N-terminally cleaved to a 32 kDa enzymatically active fragment. Both the 80 kDa and the N-terminal 32 kDa (amino acids 1-323) protein are able to perform the dehydrogenase reaction not only with steroids at the C17 position but also with -3-hydroxyacyl-coenzyme A (CoA). The enzyme is not active with -stereoisomers. The central part of the 80 kDa protein (amino acids 324-596) catalyzes the 2-enoyl-acyl-CoA hydratase reaction with high efficiency. The C-terminal part of the 80 kDa protein (amino acids 597-737) facilitates the transfer of 7-dehydrocholesterol and phosphatidylcholine between membranes in vitro. The HSD17B4 gene is stimulated by progesterone, and ligands of PPAR (peroxisomal proliferator activated receptor alpha) such as clofibrate, and is down-regulated by phorbol esters. Mutations in the HSD17B4 lead to a fatal form of Zellweger syndrome.
INTRODUCTION
The genetics and biochemistry of steroid conversion have recently been developing very fast. There is a growing body of reports showing the involvement of steroid converting enzymes in several human disorders. In this review we will focus on the most unique protein among the 17 -hydroxysteroid dehydrogenases, the type 4 enzyme. For the sake of clarity we will use the abbreviation 17 -HSD 4, although, as will be discussed later, alternative names are used frequently. The complexity of related enzymes was reviewed recently elsewhere (Reed 1991 , Andersson 1995 , Poutanen et al. 1995 , Penning 1997 ).
-hydroxysteroid dehydrogenases (-HSDs).
Several enzymes with close substrate specificity participate in that process. The identification and characterization of individual human 17 -HSDs was limited by the minute amounts of tissue available for purification. However, analyses performed with homogenates or with subcellular fractions allowed the kinetical differentiation of several enzymes such as the soluble 17 -hydroxysteroid oxidoreductase of placenta or the structure-associated 17 -estradiol dehydrogenase of uterus epithelium (Engel & Groman 1974 , Tseng & Gurpide 1974 , Tseng & Mazella 1981 . Before molecular biology techniques became widespread, the readily available human placenta allowed the purification of the first human 34 kDa 17 -hydroxysteroid dehydrogenase (17 -HSD 1), which became a model for studies of steroid converting enzymes. After cloning and elucidation of the gene structure (Peltoketo et al. 1988 , Luu-The et al. 1989 , it represents the best characterized human steroid dehydrogenase. In vivo this enzyme participates in the synthesis of steroids via a reductive pathway. However, detailed kinetical studies (Blomquist et al. 1985) have shown that the placenta expresses additional HSDs and one of them, namely 17 -HSD 2, was cloned (Wu et al. 1993) (Table 1 ). This enzyme is a 43 kDa microsomal dehydrogenase revealing a twofold higher rate of oxidation than reduction for both estrogens and androgens. A further enzyme, 17 -HSD 3, is most abundant in testes and represents a transmembrane microsomal 35 kDa protein with a strong preference for the reduction of androgens (Geissler et al. 1994) . Mouse and human 17 -HSD type 5 has not yet been fully characterized (Deyashiki et al. 1995 , Zhang et al. 1995 . However, this enzyme has wide tissue distribution and has also been identified as 3 -HSD type 2 (Lin et al. 1997 ) (for a review see Penning et al. 1997) . Later, we will discuss the issue of multifunctionality in more detail.
The oxidative 17 -HSD activity found in human uterus endometrium could not be unequivocally ascribed to the known enzymes (Tseng & Mazella 1981) . Attempts to isolate the endometrial 17 -HSD from the particulate fraction of homogenates (Pollow et al. 1976 ) resulted in a 40-fold enrichment. However, because of difficulties in collecting and the paucity of starting material, the enriched fractions were not applied to amino acid sequencing and antibody production. Entenmann et al. (1980) discovered oxidative activity for 17 -estradiol in porcine endometrium. This microsomal activity revealed comparable kinetical parameters (NAD + -dependency, K m less than 1 µM). The parameters suggested a role in the inactivation of hormones.
PURIFICATION OF PORCINE 17 -ESTRADIOL DEHYDROGENASE 4
To accomplish identification of a novel 17 -HSD we have used a pig (Sus scrofa) model. The epithelial layer of the porcine uterus could easily be collected at a preparative scale by curettage (Sierralta et al. 1978) . The 17 -estradiol dehydrogenase activity had to be solubilized from the particulate fraction (Adamski et al. 1992a) . Extracts were applied to DEAE-Sepharose, depleted of free detergent on Amberlite XAD-2 and further purified by affinity chromatography on blue Sepharose (Adamski et al. 1992b) . Further purification on butyl Sepharose resulted in two products rich in 17 -estradiol dehydrogenase activity: a major moderately hydrophobic fraction (EDH) and a minor very hydrophobic fraction (VHF). They were processed in parallel by gel filtration and ionexchange chromatography on Mono S. The EDH fraction was purified to homogeneity and revealed a (Lin et al. 1997; Zhang et al. 1995 
Both purification products, the EDH and the VHF, show the same K m for steroids and cofactors as those measured with two-substrate kinetics in the particulate fraction of homogenates of porcine uterus epithelium (Table 2) . They reveal an ordered mechanism of reaction with the cofactor binding first (Adamski et al. 1992b , Marks 1992 . EDH and VHF also share the same substrate specificity, which is highest for 17 -estradiol and, unexpectedly, comparably high for 5-androstene-3 ,17 -diol (K m =0·2 µM). Other androgens or progestagens are not converted. The molecular mass was estimated in denaturing SDS-PAGE and under native conditions by gel filtration and density gradient centrifugation (Adamski et al. 1992b) . The 32 kDa protein has a capability of forming dimers with an apparent molecular weight of 75 kDa (Carstensen et al. 1996) . The interactions in the VHF are more complex. Both gel filtration analyses and density gradient centrifugation revealed the presence of a heterogeneous complex with at least two molecular mass forms of 170 kDa and 240 kDa.
CLONING OF THE PORCINE, HUMAN AND MOUSE 17 -ESTRADIOL DEHYDROGENASE TYPE 4
With degenerated PCR-primers, designed according to partial amino acid (aa) sequence of the 32 kDa protein, a fragment of 405 base pairs (bp) was amplified from porcine endometrium cDNA. It had a single open reading frame coding for an amino acid sequence which was identical to the 32 kDa protein as confirmed by Edman degradation. Using this fragment as a probe, a 3 kb cDNA was isolated from a porcine ZAP kidney cDNA library. The sequence was later confirmed in porcine uterus (Leenders et al. 1994a) . The cDNA coded for a protein of 80 kDa consisting of 737 aa and was not similar to any known steroid dehydrogenases. About 70% of its amino acid sequence was already known from peptides of the 32 and 80 kDa proteins. Screening of human and mouse cDNA gt11 libraries of liver was performed with porcine enzyme cDNA. Novel 3 kb cDNAs were identified which coded for proteins of 735 and 736 aa representing the human and mouse counterparts respectively of the porcine enzyme (Adamski et al. 1995 , Normand et al. 1995 .
PARALLEL WAYS OF HSD17B4 IDENTIFICATION
The product of the HSD17B4 gene, an 80 kDa protein, was detected almost in parallel by other groups. During studies on peroxisomal -oxidation of pristanic acid and bile acid intermediates in rat and man, 80 kDa -specific hydroxyacyl-coenzyme A (CoA) dehydrogenase/hydratase (also called multifunctional protein 2-MFP2) were purified (Novikov et al. 1994 , Qin et al. 1997b , characterized and cloned (Dieuaide-Noubhani et al. 1996a , 1997a ,b, Jiang et al. 1996 , Novikov et al. 1997 . The amino acid sequence of the human enzyme was identical to that of 17 -HSD 4 (Adamski et al. 1995) .
Guinea pig enzyme was cloned from a cDNA library while using rat 17 -HSD 4 as a probe (Caira et al. 1998) .
Another study pursued the identification of cDNAs up-regulated in rat by peroxisomal proliferators such as WY14,643 (Corton et al. 1996 . One of the affected proteins turned out to be the rat ortholog of previously known porcine, mouse and human 17 -HSD 4.
Unusual was the way that chicken protein was identified (Kobayashi et al. 1997) . A monoclonal antibody 3b5 was prepared against isolated retinal pigment epithelium cells. The antibody recognized a 75 kDa protein on western blots of retinal pigment epithelium. This antibody was then used to screen a lambda expression library. This approach resulted in the identification of a full length cDNA clone coding for the chicken 17 -HSD 4.
Amino acid identities between 17 -HSD 4 from different species are very high, around 80% (Fig. 1) . Several hydroxysteroid dehydrogenases could be traced to a common ancestor close to 3-ketoacylacyl carrier protein reductase of Eschericia coli (Baker 1996). Phylogenetic studies suggest a common ancestor for the 17 -HSD 1 and 2, whereas the 17 -HSD 3 and 4 are examples of convergence (Baker 1994 (Baker , 1996 . In particular 17 -HSD 4 appears to be a very ancient protein whose functionality and amino acid sequence are strongly conserved. Similarities to proteins of primitive organisms will be discussed in the gene structure section.
NAMES USED
Due to multifunctionality of the encoded protein, the HSD17B4 gene product was discovered by many groups using different strategies. Because of that there are several names being used. Table 3 gives a summary of them. The references given should be understood as a source for the representative description. Quite often different synonyms are used in the same reports, depending on the functionality analyzed.
GENE STRUCTURE
The chromosomal assignment and structure of the human HSD17B4 gene were determined recently (Leenders et al. 1996a , Novikov et al. 1997 . The HSD17B4 gene localizes to chromosome 5q2 and was found to be more than 100 kbp in length (Fig. 2) . The size of the exons ranges from 21 bp (exon 5) to 286 bp (exon 13). The smallest intron with 100 bp was found between exons 5 and 6. The N-terminal domain of 17 -HSD 4 reveals functional similarity and amino acid homology (54%) to the family of short chain alcohol dehydrogenases (SCAD) (Persson et al. 1991 , Leenders et al. 1994b , Jörnvall et al. 1995 and the central domain to several fatty acid hydratases (HDE), especially to that of Candida tropicalis (40%) (Baker 1996) . However, neither sizes of the corresponding genes nor the exon/intron structures are analogous. As discussed later, the 17 -HSD 4 is an exception in the group of 17 -HSDs, since it  1. Alignment of amino acid sequences of 17 -HSD 4 from different species. Sequences were ordered to obtain maximum similarity with ClustalX software. Identical amino acids are grey shaded, similar amino acids are boxed. Accession numbers for protein sequences are: mouse, P51660; chicken, U77911; rat, U37486; human, P51659; porcine, X78201; guinea pig, Y13623.
consists of 3 domains. Only the N-terminal domain of 320 amino acids participates in steroid metabolism and is coded by 12 exons spanning about 40 kbp. In comparison to other 17 -hydroxysteroid dehydrogenases, the SCAD domain of the HSD17B4 gene is much bigger than the 17 -HSD 1 (6 exons on 3·3 kbp) (Luu-The et al. 1990 ), close to the 17 -HSD 2 (7 exons on 40 kbp) (Labrie et al. 1995) and smaller than the 17 -HSD 3 (11 exons on 60 kbp) (Geissler et al. 1994) .
The amino acid sequence C-terminal domain of 17 -HSD 4 reveals 40% identity and the same functionality as the C-terminal domain (sterol carrier protein (SCP) 2) of the SCPX protein (Ohba et al. 1994 , Leenders et al. 1996b . Interestingly, the gene structure of the last 3 exons is also similar. This observation supports the hypothesis that the HSD17B4 gene is the result of a gene fusion.
PROCESSING OF 80 kDa PROTEIN
Some peroxisomal proteins (SCP2, 3-ketoacyl-CoA thiolase) are cleaved from larger precursors in the  3. Names used for the HSD17B4 gene product et al. (1996)  2. Structure of 17 -HSD 4 protein and HSD17B4 gene. A schematic structure of the human 17 -HSD IV protein is given above that of the gene. Arrows point to the position of the G16S mutation, cleavage site and C-terminal peroxisomal targeting signal. The black boxes representing exons are drawn to scale according to the indicated 10 kb marker. The sizes of introns are given above: introns smaller than 7 kb are drawn to scale, larger introns are represented by broken lines. The numbers of the exons are below the boxes. Exons 1 and 24 consist of translated (black box) and untranslated (grey box) regions. Accession numbers for the nucleotide sequence are AF057720-AF057740.
course of translocation (Swinkels et al. 1991) . A protease present in peroxisomes has been proposed to recognize the sequence Ala-[AlaVal]-Pro (Mori et al. 1991) . The 80 kDa full length HSD17B4 gene product is N-terminally cleaved, probably after the sequence Ala 320 -Ala-Pro-Ser 324 , to a 32 kDa fragment representing a SCAD domain (Leenders et al. 1994b) . Such processing has also been observed in mice and rats (Novikov et al. 1994 , Normand et al. 1995 , Dieuaide-Noubhani et al. 1997b ) although the protease recognition motif was not conserved. The meaning of this cleavage for 17 -HSD 4 is not known. Interestingly, the extent of processing of 80 kDa into 32 kDa varies among porcine tissues (Adamski et al. 1997) . Western blot analyses of porcine organs revealed that target tissues (uterus and mammary glands) show high processing. In these tissues the 32 kDa form dominates. On the other hand, non-target tissues participating in -oxidation of fatty acids (such as liver or kidney) showed low processing. Nevertheless, in either tissue both proteins are present. The differential processing raised the question whether the release of the 32 kDa fragment from the 80 kDa protein is an activation step for 17 -hydroxysteroid dehydrogenase. However, both 80 and 32 kDa proteins had comparable kinetical parameters after transient expression in HEK 293 cells or purification of recombinant proteins from E. coli (Leenders et al. 1996b , Adamski et al. 1997 . Also the preferred reaction direction, i.e. oxidation, remained unchanged for purified, recombinant and transiently expressed proteins.
TISSUE DISTRIBUTION
In the porcine tissues studied, the oxidation of 17 -estradiol predominates over the reduction.
Highest activities are found in liver and kidney followed by uterus, lung, ovary and testes (Table 4) .
Immunohistochemical analysis of tissues showing low 17 -HSD 4 mRNA expression, such as brain, lung and uterus, reveals that the enzyme is present in specific cells within these organs. In the rat and mouse cerebellum 17 -HSD 4 is confined to Purkinje cells, and the expression is also seen in the anterior pituitary (Normand et al. 1995) . There is high expression of 17 -HSD 4 in chick retinal pigment epithelium but not in other parts of the eye (Kobayashi et al. 1997) . In the lung the bronchial epithelium expresses high levels of 17 -HSD 4 and in the uterus the protein is present in luminal and glandular epithelium and not in stromal cells (Husen et al. 1994) .
A slightly different expression pattern was seen in human tissues. The highest mRNA level of human 17 -HSD 4 was observed in liver, followed by heart, prostate and testis. Moderate expression occurred in lung, skeletal muscle, kidney, pancreas, thymus, ovary, intestine and term placenta. Weak signals were observed in brain, spleen, colon and lymphocytes. In all cases only a single band at 3 kb was detectable (Adamski et al. 1995) . The wide distribution of 17 -HSD 4 may in part explain oxidative activities measured in human tissues (Martel et al. 1992) . The expression of 17 -HSD 4 is in contrast with that of 17 -HSD 1 and 2 which are predominantly seen in the placenta.
Several human cancer cell lines also express 17 -HSD 4. The estrogen receptor positive mammary cell line, T47D, expresses more 17 -HSD 4 mRNA transcript than BT-20, MDA-MB-453 and MDA-MB-231 cell lines which are estrogen receptor negative. The megakaryotic cell line, DAMI, reveals a very high level of 17 -HSD 4 mRNA while less is present in hepatocellular carcinoma HEP-G2 and early embryonic Tera-1  4. Distribution of 17 -estradiol dehydrogenase activity in porcine tissues , Castagnetta et al. 1997 . Interestingly, 17 -HSD 2, which appears to be the principal isozyme expressed in the prostate, is present only in PC3 cells (Delos et al. 1995 , Elo et al. 1996 , Castagnetta et al. 1997 . Most probably, 17 -HSD 2 is the main protective dehydrogenase in the prostate.
REGULATION OF HSD17B4
Porcine 17 -hydroxysteroid dehydrogenase 4 is the first peroxisomal enzyme known to be stimulated by progesterone as checked by mRNA expression and immunohistochemistry (Kaufmann et al. 1995) . In the early 1970s the hormone was observed to increase estradiol oxidation in human tissues (Tseng & Gurpide 1975 , 1979 . Later it was shown to up-regulate 17 -HSD 1 in human breast cancer cells (Poutanen et al. 1990) and to increase mRNA expression of 17 -HSD 2 in human endometrium (Casey et al. 1994) . Although 17 -HSD 1 is supposed to participate in the synthesis and 17 -HSD 4 in the inactivation of steroids there is a simultaneous expression of both enzymes in gonads (Luu-The et al. 1990 , Carstensen et al. 1996 . However, the corresponding regulatory pathways of protein kinase C are not controlled in the same way. In vitamin D-differentiated human leukemia THP 1 cells, 17 -HSD 4 mRNA was stimulated twofold by dexamethasone but it was completely downregulated by phorbol esters (Jakob et al. 1995 (Jakob et al. , 1997 . This is in contrast to the dose-and time-dependent increase in gene transcripts of 17 -HSD 1 under similar treatment (Tremblay & Beaudoin 1993) .
The recently purified and cloned rat 80 kDa homolog of human 17 -HSD 4 is up-regulated by peroxisomal proliferators such as clofibrate and WY 14,643 (Novikov et al. 1994 , Corton et al. 1995 . In the PPAR (peroxisomal-proliferator activated receptor alpha) knock-out mice the expression of 17 -HSD 4 is low and does not change after treatment with WY 14,643 (Aoyama et al. 1998) . The 80 kDa protein seems to be controlled by modulators of both steroid and fatty acid metabolism. Another example of PPAR -mediated regulation is the activation of steroid metabolizing enzyme, NADP + -dependent 3 -HSD in human liver by derivatives of clofibrate (Matsuura et al. 1996) . In contrast, the guinea pig ortholog is so far the only species in which the same treatment causes a down-regulation (instead of up-regulation) of the expression of 17 -HSD 4 (Caira et al. 1998).
SUBCELLULAR DISTRIBUTION OF PORCINE 17 -HSD 4
Immunocytochemical and immunofluorescence studies in porcine uterus restricted porcine 17 -HSD 4 to luminal and glandular epithelium (Husen et al. 1994 ) similar to analyses of human endometrium (Scublinsky et al. 1976 , Mäentausta et al. 1991 . However, the staining in the cytoplasm was not diffuse but showed a punctuate appearance. The intensity of the monoclonal antibody F1-peroxidase staining followed the changes in porcine 17 -hydroxysteroid dehydrogenase activity. It was raised fourfold after day 5 of the ovarian cycle and rapidly decreased after day 17 in a manner similar to the levels of progesterone. On day 4 faint spots of fluorescence appeared in the cytoplasm of the glandular epithelium. The spots accumulated at the cell bases between days 11 and 17 (luteal phase) and disappeared within one day. The pattern of immunofluorescence staining suggested that porcine 17 -HSD 4 is localized in vesicles. The latter have been isolated from porcine uterus epithelium homogenates by sequential density gradients of isopycnic 30% Percoll and linear 0·3-2 M sucrose in vertical rotors (Adamski et al. 1987 , Adamski 1991 , Adamski et al. 1993 . The vesicles harboring the 17 -HSD activity equilibrated at a density of 1·18 g/ml, were 120-200 nm in diameter, revealed a moderate electron-dense matrix bounded by a single membrane and were morphologically and enzymatically distinct from mitochondria, lysosomes, fragments of plasma membrane, endoplasmic reticulum and the Golgi apparatus. In immunogold electron microscopy the labeling with monoclonal antibody F1 (recognizing the 32 kDa and the 80 kDa protein) and W1 (reacting with 32 kDa only) confirmed that all forms of the enzyme are present in the same vesicles, both in tissue and in the isolated fraction (Adamski et al. 1993) .
Several clues pointed to the identity of the 17 -HSD 4 containing vesicles as peroxisomes: (1) the morphology and density is similar to that of peroxisomes, (2) the 80 kDa primary transcript features the peroxisomal targeting signal Ala-LysIle and a putative recognition sequence (Ala-AlaPro) for a protease processing peroxisomal protein (Mori et al. 1991) and (3) the 80 kDa protein is similar to enzymes participating in peroxisomal -oxidation of fatty acids. Indeed, typical peroxisomal markers such as catalase and acyl-CoA oxidase co-localized with porcine 17 -HSD 4 in immunogold labeling studies in uterus, kidney and liver (Markus et al. 1995a,b) .
In other species, such as the rat, 17 -HSD 4 was indeed purified from isolated peroxisomes (Novikov et al. 1994) . However, at that time the amino acid sequence of the rat enzyme was not known.
Peroxisomal localization of 17 -HSD 4 extends our understanding on how steroid, sterol and bile acid metabolism are interlinked. Different subcellular distribution of various 17 -HSDs allows for local control of their activities. Peroxisomes were initially believed to play only a minor role in mammalian metabolism. However, they play an indispensable role in many metabolic pathways, like synthesis of cholesterol, -oxidation of fatty acids, biosynthesis of ether lipids and bile acids, -oxidation of phytanic acid and, as depicted in this review, oxidation of steroids (Wanders et al. 1995 , Krisans 1996 , Magalhaes & Magalhaes 1997 , Verhoeven et al. 1997 , Seedorf et al. 1998 ).
MULTIFUNCTIONALITY OF 17 -HSD 4
In order to check for the presence of activities predicted by amino acid similarities of the 80 kDa protein (Fig. 2) its three domains were expressed separately (Leenders et al. 1996b) . The N-terminal domain (aa 1-323) catalyzed both the 17 -hydroxysteroid and the 3-hydroxyacyl-CoA dehydrogenase reactions (Table 5 ). Kinetic parameters (K m , V max ) of the expressed full length 80 kDa protein were close to those observed for the single expressed domains or for the native purified enzyme (EDH or VHF) (Leenders et al. 1996b) .
This was the first observation of an enzyme performing dehydrogenase activity not only with steroids but also with 3-hydroxyacyl-CoA derivates of fatty acids. Furthermore, the central domain (aa 324-596) was responsible for the 2-enoyl-acylCoA hydratase activity. Essentially the same data concerning conversion of 3-hydroxyacyl-CoAs and 2-enoyl-acyl-CoAs were obtained simultaneously with expressed or purified proteins of the rat (Novikov et al. 1994 , Qin et al. 1997a . Estimated K m values for the hydratase and fatty acid dehydrogenase are similar to those of other enzymes of -oxidation of fatty acids (Steinman & Hill 1975 , Palosaari & Hiltunen 1990 ). Both K m for steroids and fatty acids are in the physiological range.
Further studies on peroxisomal -oxidation of fatty acids and precursors of bile acids demonstrated that the 17 -HSD 4 specifically forms and dehydrogenates -3-hydroxyacyl-CoAs and not their -stereoisomers (Dieuaide-Noubhani et al. 1997a , Jiang et al. 1997 . This differentiates the 
1996).
Recombinant 32 kDa and 80 kDa proteins were assayed in homogenates of transfected cells and were corrected for background conversion (Carstensen et al. 1996) . The recombinant central domain was characterized after purification on glutathione-agarose and thrombin cleavage. ND, activity not detected.
enzyme from the multifuntional enzyme 1 (MFP1) (Osumi et al. 1985b) which is -specific. The velocity of 17 -estradiol oxidation by porcine, mouse and human 17 -HSD 4 is several fold lower than that of fatty acyl-CoA (Leenders et al. 1994a , 1996b , Adamski et al. 1995 , Normand et al. 1995 . The same observation was made in rat (Dieuaide-Noubhani et al. 1996b , Qin et al. 1997b ). However, all other known 17 -HSDs have the same conversion rates for steroids within the range 0·1 to 2·45 nmol/min/mg protein (Table  1) . Because the enzymatic parameters (V max , K m ) of the 17 -HSD 4 for both fatty acyl-CoA and steroids are close to those known for other enzymes of the SCAD gene family it remains to be settled which substrates are physiological.
In comparison to other 17 -HSDs the type 4 enzyme accepts the most structurally diverse substrates. Human 17 -HSD 1-3 and mouse and rat 17 -HSD 7 (Nokelainen et al. 1998) are practically only active with steroids at position 17. However, 17 -HSD 5 and the recently cloned rat 17 -HSD 6 (Biswas & Russell 1997) must be considered multifunctional because of their 3 -hydroxysteroid dehydrogenase activity. Actually, 17 -HSD 5 was first identified in a row of different 3 -HSDs and assigned type 2 among them (for reviews see Lin et al. 1997 , Penning 1997 . One 3 -HSD was even first identified as a bile acid binding protein (Nanjo et al. 1995) .
Interesting is the novel 17 -hydroxysteroid dehydrogenase previously known as Ke6 protein in mouse and human (Ando et al. 1996 , Formicheva et al. 1998 . This enzyme which might be termed 17 -HSD 8 has a V max of 0·27 nmol/min/mg protein with 17 -estradiol/NAD + and reveals the highest (37%) amino acid sequence identity among the 17 -HSDs to 17 -HSD 4. It remains to be verified if 17 -HSD 8 is able to metabolize bile acids or fatty acids.
ROLE OF SCP2 DOMAIN
The most C-terminal part of the 80 kDa protein (amino acids 597-737) has 39% similarity to rat SCP2 (Leenders et al. 1994b) . This non-specific lipid transfer protein is highly conserved, even in evolutionarily distant species such as chicken and human (Yamamoto et al. 1991 , Pfeifer et al. 1993 . This product of an SCPX gene, which actually encodes two proteins, SCP2 and SCPX, is a fusion between SCP2 and thiolase (Ohba et al. 1994 , Seedorf et al. 1994 . SCP2 is a 13 kDa basic protein believed to participate in the intracellular movement of cholesterol and lipids (Wirtz 1997) .
The role of SCP2 in steroidogenesis and arteriosclerosis has been extensively studied (Seedorf et al. 1993 , Krisans 1996 , Magalhaes & Magalhaes 1997 . A synopsis of this functionality is beyond the scope and limits of this review.
The role of the SCP2 domain for the functionality of 17 -HSD 4 is not clear. The expressed porcine SCP2 domain facilitates the transfer of 7-dehydrocholesterol and phosphatidylcholine between membranes in vitro. The activities of the N-terminal domain towards steroids or fatty acyl-CoA are not changed if the SCP2 domain is deleted (Leenders et al. 1996b) .
Recently, gene targeting in mice was used to study the unknown function of SCP2 (Seedorf et al. 1998) . In the Scp2(-/-) mice with complete deficiency of SCP2 and SCPX, marked alterations in gene expression, peroxisome proliferation, hypolipidemia, impaired body weight control, and neuropathy were observed. Knock-out mice showed impaired catabolism of methyl-branched fatty acyl-CoAs, especially of the tetramethyl-branched fatty acid, phytanic acid. The gene disruption led to inefficient import of phytanoyl-CoA into peroxisomes and to defective thiolytic cleavage of 3-ketopristanoyl-CoA.
MUTATIONS IN THE HSD17B4 GENE
Recent research on peroxisomal disorders revealed that 17 -HSD 4 is deficient in Zellweger syndrome (Novikov et al. 1997 , Suzuki et al. 1997 , van Grunsven et al. 1998 . Peroxisomal organelle deficiency results in disorders of lipid, fatty acid and sterol metabolism such as Zellweger syndrome, adrenoleukodystrophy, infantile refsum disease and hyperpipecolic acidemia (Lazarow & Moser 1995 , Wanders et al. 1995 . Patients with peroxisomal deficiency reveal high plasma concentrations of long chain fatty acids, bile acids and deficient synthesis of plasmalogens. This exerts pleiotropic influence of renal functions impairment and neuronal development (neuronal migration defects and degeneration).
One example of the molecular basis of the recently identified 17 -HSD 4 deficiency is the mutation G16S (van Grunsven et al. 1998 ). This mutation is localized in the first exon (Fig. 2) and disturbs the conformation of the Rossman fold required for cofactor (NAD + ) binding. The mutant is inactive with both steroids and bile acids (van Grunsven et al. 1998 ). The mutation is lethal, most probably because the -specific pathways of pristanic acid and di/tri-hydroxycholestanoic acid metabolism are disrupted. As mentioned above, the multifunctional protein 1 (Osumi et al. 1985a ) is -specific and cannot substitute the deficient -pathway (Dieuaide-Noubhani et al. 1997a) . Because 17 -HSD 4 has a ubiquitous distribution, any mutation would affect the whole organism. In addition, developmental studies have shown that this enzyme is present as early as at least day 7 post coitus of embryonic development (Mustonen et al. 1997) . The lack of observation of any steroid hormone related phenotype might be due to compensation by other 17 -hydroxysteroid dehydrogenases. Table 1 compares human 17 -HSD 1-5 and depicts differences in catalytic parameters, posttranslational processing and subcellular localization. The catalytical property of 17 -HSD 4, revealing the virtually unidirectional oxidative activity, clearly defines it as a steroid inactivating enzyme (Gurpide & Marks 1981) , since it produces estrone which shows little affinity to the estradiol receptor. The conversion of 17 -estradiol to estrone might be complemented by hydroxylations in positions 6 or 7 (Maschler et al. 1983 ) producing steroids devoid of estradiol receptor affinity and permitting fast release from cells after formation. The V max and K m values for EDH are similar to those for estrone hydroxylases (Adamski et al. 1994) and allows the metabolic conversion 17 -estradiol<estrone<6 / 7 -hydroxy-estrone without rate-limiting steps.
PHYSIOLOGICAL SIGNIFICANCE IN STEROID METABOLISM
Our discovery of 17 -HSD 4 in peroxisomes stimulated discussions about the possible role of peroxisomes in steroid metabolism (Markus et al. 1995b) . The enzyme has an as yet unseen ability to be stimulated by both (1) progestins (Kaufmann et al. 1995) , which is a common feature of other 17 -HSDs (Tseng & Gurpide 1975 , Poutanen et al. 1990 , and (2) peroxisomal activators such as WY14,643 (Corton et al. 1996 (Corton et al. , 1997 or clofibrate (M Markus & J Adamski, unpublished results). The stimulation produces a tissue-specific response: progestins induce about a tenfold increase in 17 -HSD 4 mRNA and protein synthesis in the uterus epithelium but not in liver whereas clofibrate treatment has no effects on uterus but results in a threefold induction in the liver. It is not known whether the differences are caused by local concentrations of receptors, modulation of receptor action by spatially restricted factors or alternated promoter usage similar to that observed for the estrogen receptor in osteoblasts and breast tissue (Grandien et al. 1995) . 17 -HSD 4 inactivates the conversion of 5-androstene-3 , 17 -diol to dehydroepiandrosterone (DHEA), a known peroxisomal proliferator (Prough et al. 1994) . Although both DHEA and clofibrate induce peroxisomes they have opposite effects on the concentrations of triglycerides and cholesterol in blood. DHEA increases the levels of lipids while clofibrate acts as a hyperlipidemic drug. Decreased expression of enzymes which inactivate estradiol, including Cyp2C11, and the reported increased expression of aromatase (converting testosterone to estradiol) may explain why male rats exposed to diverse peroxisomal proliferators have higher serum estradiol levels. These higher estradiol levels in male rats have been thought to be mechanistically linked to Leydig cell hyperplasia and adenomas. Increased conversion of estradiol to the less active estrone by 17 -HSD 4 induction may explain how exposure to the di-(2-ethylhexyl)-phthalate leads to decreases in serum estradiol levels and suppression of ovulation in female rats (Srivastava & Srivastava 1991 , Corton et al. 1997 .
